This study documents the differential requirements of T4+ T helper cells in the induction of virus-specific cytotoxic T-lymphocyte (CTL) and antibody responses during acute lymphocytic choriomeningitis virus infection. Two monoclonal antibodies (GKI.5 and RL172.4) directed against the L3T4 (T4) molecule were used for depleting T helper cells from mice. Depletion of T4+ cells caused a pronounced suppression of antiviral antibody response (20-fold decrease) but had minimal effect on virus-specific CTL response (<2-fold reduction). Despite the elimination of >90% of T helper cells, anti-L3T4-treated mice were able to generate a CTL response of sufficient magnitude to control the viral infection. In contrast, depletion of Lyt2+ T cells abrogated the CTL response and the ability to eliminate virus. Thus, our results underscore the importance of the Lyt2+ T-cell subset in controlling infection with this virus and show that a deficiency of T4+ T cells is likely to have a more severe effect on antibody production than on CTL responses.
T helper cells, characterized by surface expression of the T4 molecule, play a central role in the generation of immune responses (4, 8, 10, 12, 13, 29, 30) . It is generally accepted that T4+ T cells provide help for antibody production as well as for the induction of Lyt2+ cytotoxic T lymphocytes (CTL). The relative requirements of T4+ T helper cells in the generation of humoral responses versus the induction of CTL effector functions are not fully understood. In this report we examined the role of T4+ cells in the development of antiviral antibody and CTL responses following infection of mice with lymphocytic choriomeningitis virus (LCMV). Two monoclonal antibodies (MAbs), GK1.5 and RL172.4, against the cell surface molecule L3T4 were used to deplete T helper cells. We found that elimination of >90% of T helper cells caused a marked suppression of antiviral antibody response but had minimal effect on virus-specific CTL response. All anti-L3T4-treated mice generated an LCMVspecific CTL response that was of sufficient magnitude to control the viral infection. These results suggest that a deficiency of T4+ T helper cells is more likely to affect antiviral antibody production than the induction of virusspecific CTL.
MATERIALS AND METHODS
Mice. BALB/cByJ (H-2d) and C57BL/6 (H-2b) mice (6 to 8 weeks old) were purchased from the Jackson Laboratory, Bar Harbor, Maine.
Virus. The Armstrong CA1371 strain of LCMV (Arm-7) was used in this study (3) .
MAbs. The rat anti-mouse hybridoma MAb GK1.5 was obtained from the American Type Culture Collection, Rockville, Md. This antibody reacts with the L3T4 (T4) molecule and is of the immunoglobulin G2b (IgG2b) subclass (11 body (IgM) also reacts with the L3T4 molecule and is effective in complement-mediated in vitro depletion of T4+ cells (9) . The AD4(15) MAb was purchased in the form of ascites fluid from Cedarlane and used at concentrations specified by the supplier to deplete Lyt2+ T cells.
T-cell subset depletion. Two protocols were used for depleting L3T4+ cells. (i) For in vivo treatment with GK1.5, mice were injected intraperitoneally (i.p.) with a total of 1.5 mg of GK1.5 antibody. This was given in five doses of 300 ,ug each on days -3, -1, +1, +3, and +5 (mice were challenged with virus on day 0). (ii) The second protocol used two MAbs against L3T4: RL172.4 for complement-mediated depletion in vitro followed by in vivo treatment with GK1.5. The in vitro treatment with RL172.4 was done as described (2) . Briefly, 3 x 108 spleen cells at a concentration of 108/ml were treated with RL172. 4 and rabbit complement (low tox M; Cedarlane). To ensure effective depletion of L3T4+ cells, the cytotoxicity procedure was done twice. The cytotoxic index (CI) was calculated as follows: CI = 100 x [(% cytotoxicity of antibody and complement -% cytotoxicity of complement alone)/(100 -% cytotoxicity of complement alone)]. The RL172. 4 a In experiment 1, BALB/cByJ mice were injected i.p. with 300 ,ug of anti-L3T4 MAb (GK1.5) on days -3, -1, +1, +3, and +5 (total, 1.5 mg). The control group received five injections of PBS. All mice were infected i.p. with 105 PFU of LCMV on day 0. LCMV-specific CTL, antibody, and virus titers were checked eight days postinfection. In experiment 2, spleen cells from BALB/cByJ mice were first treated in vitro with RL172.4 plus complement. These anti-L3T4-treated cells were transferred i.v. into irradiated (650 rads) mice (5 x 107 cells per mouse) and then treated in vivo with GK1.5 (300 ,ug each on days -1, 0, and + 1). For the control group, spleen cells were treated in vitro with complement only and transferred into irradiated mice (5 x 107 cells per mouse). These mice were then injected with PBS instead of GK1.5. All mice were challenged with virus on day 0. LCMV-specific CTL and antibody responses and virus titer were checked 8 days postinfection.
b E:T ratio, Effector/target cell ratio. Not all ratios were tested with all groups.
The LCMV-specific CTL response was calculated as lytic units (LU) per 107 spleen cells. One lytic unit is defined as the number of lymphocytes needed to kill 30% of infected targets in a 6-h assay.
Antibody titrations. LCMV-specific antibody was measured as described previously (3) by a solid-phase enzymelinked immunosorbent assay (ELISA) with purified virus as the antigen.
Cytotoxicity assay. LCMV-specific CTL activity in the spleen was determined by a 6-h 51Cr release assay (3) . All samples were assayed in triplicate, and the standard error was <2%.
Virus titrations. Infectious LCMV in serum and tissues was quantitated by plaque assay on Vero cell monolayers as described previously (3) . Even mice that showed minimal to no effect on the CTL response (0 to 20% suppression) exhibited 97 to 99% suppression of LCMV-specific antibody response. The anti-L3T4 treatment had no effect on the ability of mice to clear the viral infection. There was no detectable infectious virus in the serum, spleen, or liver of these mice at 8 days postinfection. In contrast, mice made immunodeficient by whole-body irradiation (650 rads) contained high levels of virus. Effect of anti-Lyt2 treatment on LCMV-specific immune response and ability to eliminate virus. As shown in Table 2 , depletion of Lyt2+ T cells completely abrogated the CTL response and had no effect on the antibody response. AntiLyt2-treated mice were unable to resolve the infection and contained high levels of infectious virus in the serum and tissues at 8 days postinfection.
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DISCUSSION
This study documents the differential requirements of T4+ T helper cells in the induction of antiviral antibody and CTL responses. Mice treated with anti-L3T4 MAbs exhibited suppression of LCMV-specific antibody response but no effect on virus-specific CTL responses. Even after depletion of >90% of T4+ T helper cells, anti-L3T4-treated mice were able to generate a CTL response that was potent enough to control the viral infection. An important implication of these findings is that a deficiency of T4+ helper cells is likely to have a more severe effect on humoral responses than on the induction of CTL responses.
CTL play an important role in controlling viral infections. shown that Lyt2+ T cells are required for clearing LCMV from both acutely and persistently infected mice (1, 7, 19, 24, 25, 31) . However, the mechanism(s) of induction of virusspecific CTL in vivo is not fully understood. Our results suggest that T4+ T helper cells may not be required for the generation of LCMV-specific CTL and that the necessary lymphokines (such as interleukin-2 [IL-2]) are produced by the CTL themselves or by other Lyt2+ T cells. The existence of Lyt2+ "helper" T cells and the ability of Lyt2+ CTL clones to produce IL-2 have been shown in other systems (23) . Our studies do not completely rule out a requirement Mice infected with LCMV at birth or in utero become lifelong carriers, with high levels of infectious virus in most of their tissues. Such persistently infected mice are deficient in generating LCMV-specific CTL responses and also make low levels of antibody against the virus (3, 5, 21) . We have recently shown that T cells of the helper subset (T4+) are infected with LCMV during persistent infection in vivo and there is minimal or no infection of Lyt2+ T cells and mature B cells (2) . This finding implied that infection of T4+ T helper cells may be the Lnderlying cause of the suppression of LCMV-specific immune responses. The results of the present study suggest that lack of appropriate T4+ helper cells is unlikely to be the sole cause of the suppression of LCMV-specific CTL responses in carrier mice. However, it is possible that the development of memory CTL, in contrast to the generation of the primary CTL response, is more dependent on T4+ T cells. The CTL response to LCMV may progress from a T helper-independent to a more T helperdependent phase. In this case, lack of functional LCMVspecific T helper cells could still explain the suppression of LCMV-specific CTL responses in carrier mice. Studies are in progress to address this issue.
A recent study by Leist et al. (22) also examined the role of T4+ T cells in generation of the LCMV-specific CTL response by treating thymectomized C57BL/6 and CBA/J mice with anti-L3T4 MAb (YTS 191.1). They found that anti-L3T4-treated mice made a readily detectable CTL response (-70% specific killing at an effector/target cell ratio of 50:1 on virus-infected syngeneic targets, as measured by the 51Cr release assay), although the number of lytic units per spleen was about 10-fold lower than in control mice. In addition, this response was sufficient to cause the lethal choriomeningitis that is mediated by LCMV-specific Lyt2+ T cells (22) . All anti-L3T4-treated mice died at the same time as untreated mice (7 days postinfection) following intracerebral inoculation of LCMV (22) . Thus, the results of this study showing that LCMV-specific CTL responses are generated by anti-L3T4-treated mice are in agreement with our findings. Leist et al. (22) did not examine the requirement for T4+ T helper cells in the induction of LCMV-specific antibody response or in controlling viral infection.
It has been accepted as dogma that T helper cells are essential for the generation of CTL responses (4, 8, 12, 13, 29) . However, this belief has been challenged by several reports showing that Lyt2+ T cells can generate allogeneic CTL responses both in vitro and in vivo in the absence of T4+ T helper cells (26) (27) (28) . We have now shown that a potent LCMV-specific CTL response that is sufficient to control the viral infection is made by anti-L3T4-treated mice. Similar results have recently been reported for ectromelia virus (6) . In this study, GK1.5-treated mice made an optimal CTL response against ectromelia virus and recovered from the mouse pox. Thus, taken together, these studies show that antiviral CTL responses can be generated even when there is a deficiency of T4+ T helper cells. It is possible that CTL responses to some viruses may be T helper cell independent and to other viruses may be T helper cell dependent. Studies addressing this issue will better define the role of T4+ T cells in antiviral host defense mechanisms and may provide a clearer understanding of the pathogenesis of acquired immunodeficiency syndrome, a disease characterized by a deficiency of T4+ T cells and susceptibility to opportunistic infectiohs (14, 15, 17, 18, 20) .
